XFRA NEW INSTRUMENTS AVAILABLE ON XETRA

XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 09.10.2024

The following instruments on XETRA do have their first trading 09.10.2024
Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 09.10.2024

Aktien

1 US23381D1028 Daiichi Sankyo Co. Ltd. ADR
2 KYG392AS1011 Global New Material International Holdings Ltd.
3 US4928541048 Kewaunee Scientific Corp.
4 US00439U1043 Acasti Pharma Inc.

5 BMG4R86G1074 Gold Reserve Ltd.
6 SGXZ53070850 Hafnia Ltd.
7 SGXZ57724486 Maxeon Solar Technologies Ltd.
8 US8173233060 Sequans Communications S.A. ADR

Anleihen/ETF

1 XS2914770545 Kasachstan, Republik
2 BE0002219856 FLUXYS Belgium S.A.
3 DE000BU0E220 Deutschland, Bundesrepublik
4 ES0L02510102 Spanien, Königreich
5 ES0413860877 Banco de Sabadell S.A.
6 DE000HEL0AL9 Landesbank Hessen-Thüringen Girozentrale
7 DE000HLB44Y3 Landesbank Hessen-Thüringen Girozentrale
8 DE000HLB44X5 Landesbank Hessen-Thüringen Girozentrale
9 DE000HLB44Z0 Landesbank Hessen-Thüringen Girozentrale
10 IE000GBYNAU4 AXA IM ICE US Treasury +25Y UCITS ETF
11 LU2673522830 Xtrackers II Target Maturity Sept 2027 EUR Corporate Bond UCITS ETF
12 LU2673522913 Xtrackers II Target Maturity Sept 2029 EUR Corporate Bond UCITS ETF
13 LU2673523135 Xtrackers II Target Maturity Sept 2031 EUR Corporate Bond UCITS ETF
14 LU2673523051 Xtrackers II Target Maturity Sept 2033 EUR Corporate Bond UCITS ETF

Zeit	Aktuelle Nachrichten
31.03.	GLOBAL NEW MAT (06616): ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2024 AND CHANGE IN USE OF NET PROCEEDS FROM THE GLOBAL OFFERING
31.03.	GLOBAL NEW MAT (06616): FURTHER DELAY IN DESPATCH OF CIRCULAR
19.03.	GLOBAL NEW MAT (06616): NOTICE OF BOARD MEETING
28.02.	GLOBAL NEW MAT (06616): RESULTS OF A SUBSIDIARY
08.11.24	GLOBAL NEW MAT (06616): SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO PROPOSED ISSUE OF CONVERTIBLE BONDS OF UP TO US$80,000,000 UNDER GENERAL MANDATE

Zeit

Aktuelle Nachrichten

31.03.

GLOBAL NEW MAT (06616): ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2024 AND CHANGE IN USE OF NET PROCEEDS FROM THE GLOBAL OFFERING

31.03.

GLOBAL NEW MAT (06616): FURTHER DELAY IN DESPATCH OF CIRCULAR

19.03.

GLOBAL NEW MAT (06616): NOTICE OF BOARD MEETING

28.02.

GLOBAL NEW MAT (06616): RESULTS OF A SUBSIDIARY

08.11.24

GLOBAL NEW MAT (06616): SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO PROPOSED ISSUE OF CONVERTIBLE BONDS OF UP TO US$80,000,000 UNDER GENERAL MANDATE

Zeit	Aktuelle Nachrichten
Mo	Gold Reserve Ltd: Gold Reserve to plead against Red Tree's Citgo bid
Fr	Gold Reserve Ltd: Gold Reserve files lawsuits to execute against accounts
Do	Gold Reserve Ltd.: Gold Reserve Announces Filing of New Legal Actions in Portugal to Obtain Judgments Against Attached Funds	Gold Reserve Ltd. (TSX.V: GRZ) (OTCQX: GDRZF) ("Gold Reserve" or the "Company") is pleased to announce an important development in its ongoing efforts to enforce its arbitral award dated September... ► Artikel lesen
01.04.	Gold Reserve Ltd: Gold Reserve protests against Citgo bid recommendation
25.03.	Gold Reserve's $7.1B Bid For PDVH Not Recommended As Stalking Horse

Zeit

Aktuelle Nachrichten

Gold Reserve Ltd: Gold Reserve to plead against Red Tree's Citgo bid

Gold Reserve Ltd: Gold Reserve files lawsuits to execute against accounts

Gold Reserve Ltd.: Gold Reserve Announces Filing of New Legal Actions in Portugal to Obtain Judgments Against Attached Funds

01.04.

Gold Reserve Ltd: Gold Reserve protests against Citgo bid recommendation

25.03.

Gold Reserve's $7.1B Bid For PDVH Not Recommended As Stalking Horse

Zeit	Aktuelle Nachrichten
03.03.	Grace Therapeutics, Inc. - 8-K, Current Report
19.02.	Grace Therapeutics, Inc. - 10-Q/A, Quarterly Report
18.02.	H.C. Wainwright reiterates buy on Grace Therapeutics stock
13.02.	Grace Therapeutics GAAP EPS of -$0.36 misses by $0.04
13.02.	Grace Therapeutics, Inc.: Grace Therapeutics Announces Third Fiscal Quarter 2025 Financial Results, Provides Business Update	Announced Phase 3 STRIVE-ON Safety Trial Met Primary Endpoint and Provided Clinical Benefit Compared to Orally Administered Nimodipine; New Drug Application (NDA) Submission Anticipated First Half... ► Artikel lesen

Zeit

Aktuelle Nachrichten

03.03.

Grace Therapeutics, Inc. - 8-K, Current Report

19.02.

Grace Therapeutics, Inc. - 10-Q/A, Quarterly Report

18.02.

H.C. Wainwright reiterates buy on Grace Therapeutics stock

13.02.

Grace Therapeutics GAAP EPS of -$0.36 misses by $0.04

13.02.

Grace Therapeutics, Inc.: Grace Therapeutics Announces Third Fiscal Quarter 2025 Financial Results, Provides Business Update

Zeit	Aktuelle Nachrichten
20.03.	Hafnia introduces FuelSure platform to enhance transparency in bunker fuel market
19.03.	Hafnia Ltd - 6-K, Report of foreign issuer
19.03.	HAFNIA LIMITED: Resignation of Board Member
19.03.	HAFNIA LIMITED: Award of share options to primary insiders
18.03.	HAFNIA LIMITED: Mandatory Notification of Trade - Exercise of existing Restricted Share Units

Zeit

Aktuelle Nachrichten

20.03.

Hafnia introduces FuelSure platform to enhance transparency in bunker fuel market

19.03.

Hafnia Ltd - 6-K, Report of foreign issuer

19.03.

HAFNIA LIMITED: Resignation of Board Member

19.03.

HAFNIA LIMITED: Award of share options to primary insiders

18.03.

HAFNIA LIMITED: Mandatory Notification of Trade - Exercise of existing Restricted Share Units

Zeit	Aktuelle Nachrichten
14.03.	KEWAUNEE SCIENTIFIC CORP /DE/ - 10-Q, Quarterly Report
12.03.	Kewaunee Scientific Corporation: Kewaunee Scientific Reports Results for Third Quarter of Fiscal Year 2025	STATESVILLE, N.C., March 12, 2025 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced results for its third quarter ended January... ► Artikel lesen
12.03.	Kewaunee Scientific Non-GAAP EPS of $1.09, revenue of $67.17M
12.03.	KEWAUNEE SCIENTIFIC CORP /DE/ - 8-K, Current Report
26.02.	KEWAUNEE SCIENTIFIC CORP /DE/ - 8-K, Current Report

Zeit

Aktuelle Nachrichten

14.03.

KEWAUNEE SCIENTIFIC CORP /DE/ - 10-Q, Quarterly Report

12.03.

Kewaunee Scientific Corporation: Kewaunee Scientific Reports Results for Third Quarter of Fiscal Year 2025

12.03.

Kewaunee Scientific Non-GAAP EPS of $1.09, revenue of $67.17M

12.03.

KEWAUNEE SCIENTIFIC CORP /DE/ - 8-K, Current Report

26.02.

KEWAUNEE SCIENTIFIC CORP /DE/ - 8-K, Current Report

Zeit	Aktuelle Nachrichten
10:46	CBP denies Maxeon's protests against detention of modules, Maxeon to 'establish alternative' supply chains
Mo	Maxeon Solar rises on plans for alternative supply chains due to tariff chaos
Sa	Maxeon Solar shifts focus to U.S. market amid challenges
Fr	Maxeon Solar Technologies, Ltd. - 6-K, Report of foreign issuer
Fr	Maxeon Solar Technologies, Ltd.: Maxeon Provides Strategic Business Update	SINGAPORE, April 4, 2025 /PRNewswire/ -- Maxeon Solar Technologies, Ltd. (NASDAQ: MAXN), a global leader in solar innovation and channels, today provided an... ► Artikel lesen

Zeit

Aktuelle Nachrichten

10:46

CBP denies Maxeon's protests against detention of modules, Maxeon to 'establish alternative' supply chains

Maxeon Solar rises on plans for alternative supply chains due to tariff chaos

Maxeon Solar shifts focus to U.S. market amid challenges

Maxeon Solar Technologies, Ltd. - 6-K, Report of foreign issuer

Maxeon Solar Technologies, Ltd.: Maxeon Provides Strategic Business Update

Zeit	Aktuelle Nachrichten
Do	Sequans Communications regains compliance with NYSE
Do	Sequans meets NYSE listing standards after strategic moves
Do	Sequans Communications Regains NYSE Listing Compliance	Paris, France--(Newsfile Corp. - April 3, 2025) - Sequans Communications S.A. (NYSE: SQNS), a leading provider of 4G and 5G semiconductors and modules for the Internet of Things, announced today that... ► Artikel lesen
Do	SEQUANS COMMUNICATIONS - 6-K, Report of foreign issuer
11.03.	Sequans Communications Aktie: Hier blüht Zukunftspotenzial	Sequans Communications (SQNS) hat zuletzt eine vielversprechende Entwicklung gezeigt, nachdem am 11. Februar 2025 die Geschäftsergebnisse für das vierte Quartal 2024 veröffentlicht wurden. Das Unternehmen... ► Artikel lesen

Zeit

Aktuelle Nachrichten

Sequans Communications regains compliance with NYSE

Sequans meets NYSE listing standards after strategic moves

Sequans Communications Regains NYSE Listing Compliance

SEQUANS COMMUNICATIONS - 6-K, Report of foreign issuer

11.03.

Sequans Communications Aktie: Hier blüht Zukunftspotenzial

Unternehmen / Aktien	Kurs	%
GLOBAL NEW MATERIAL INTERNATIONAL HOLDINGS LTD	0,396	-3,41 %
GOLD RESERVE LTD	1,400	+16,67 %
GRACE THERAPEUTICS INC	1,850	0,00 %
HAFNIA LIMITED	3,465	-4,52 %
KEWAUNEE SCIENTIFIC CORPORATION	32,400	+1,25 %
MAXEON SOLAR TECHNOLOGIES LTD	2,680	-2,90 %
SEQUANS COMMUNICATIONS SA ADR	1,920	0,00 %

Unternehmen / Aktien

Kurs

GLOBAL NEW MATERIAL INTERNATIONAL HOLDINGS LTD

0,396

-3,41 %

GOLD RESERVE LTD

1,400

+16,67 %

GRACE THERAPEUTICS INC

1,850

0,00 %

HAFNIA LIMITED